However, the effects of RGZ on Sirt1 in in vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD) and the synergistic effects of different sirtuin isoforms on metabolic regulation have not yet been reported. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.